Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D Rebates Would Save $145Bn, CBO Says; Small Change Compared To ACA Repeal

Executive Summary

Part D rebates remain a large potential savings for legislators if and when they look at Medicare reforms. But in the upcoming push to repeal the ACA, the $145bn potential savings from rebates looks almost trivial.

You may also be interested in...



Trump Makes A Nasty News Day For Pharma – But What Will It Really Mean?

President-elect threatens a government bidding process to control drug pricing in his first post-election press conference.

Trump’s Drug Pricing Remarks: A Gambit For Industry Self-Restraint?

Comments during recent interview shows president-elect continues to view drug pricing as populist issue, revives speculation he may take action to control prices.

Trump’s HHS, CMS Leadership Choices Underscore Focus On ACA Reform

Rep. Tom Price and health policy consultant Seema Verma will spearhead Trump Administration efforts to reform the Affordable Care Act as HHS secretary and administrator of CMS, respectively.

Related Content

Topics

UsernamePublicRestriction

Register

PS119739

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel